Skip to main navigation Skip to search Skip to main content

Human African Trypanosomiasis

  • Janelisa Musaya
  • , Peter Nambala
  • , Westain Tizgo Nyirenda
  • , Julius Mulindwa
  • , David Mabey
  • Kamuzu University of Health Sciences
  • Malawi-Liverpool-Wellcome Trust Clinical Research Programme
  • Ministry of Health, Malawi
  • Makerere University
  • London School of Hygiene and Tropical Medicine

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Human African trypanosomiasis (HAT), otherwise known as sleeping sickness, comes in two forms: the West African form caused by Trypanosoma brucei gambiense, which is found in West and Central Africa, accounts for 95% of cases and has no known animal reservoir; and the East African form caused by Trypanosoma brucei rhodesiense, a zoonotic infection, which contributes 5%. HAT is endemic in 36 countries in sub-Saharan Africa (Fig. 52.1), but more than 70% of cases reported in the past 10 years have been in the Democratic Republic of Congo. It is invariably fatal unless treated. The parasites are transmitted by tsetse flies of the Glossina palpalis and G. morsitans groups.

Original languageEnglish
Title of host publicationPrinciples of Medicine in Africa
PublisherCambridge University Press (CUP)
Pages518-523
Number of pages6
Edition5
ISBN (Electronic)9781316511435
ISBN (Print)9781009052733
DOIs
Publication statusPublished - 18 Jun 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Human African Trypanosomiasis'. Together they form a unique fingerprint.

Cite this